GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (OSTO:XBRANE) » Definitions » Price-to-Tangible-Book

Xbrane Biopharma AB (OSTO:XBRANE) Price-to-Tangible-Book : 0.78 (As of Apr. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Xbrane Biopharma AB Price-to-Tangible-Book?

As of today (2024-04-28), Xbrane Biopharma AB's share price is kr0.2135. Xbrane Biopharma AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was kr0.27. Hence, Xbrane Biopharma AB's Price to Tangible Book Ratio of today is 0.78.

The historical rank and industry rank for Xbrane Biopharma AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:XBRANE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.77   Med: 6.93   Max: 16.67
Current: 0.79

During the past 11 years, Xbrane Biopharma AB's highest Price to Tangible Book Ratio was 16.67. The lowest was 0.77. And the median was 6.93.

OSTO:XBRANE's Price-to-Tangible-Book is ranked better than
87.13% of 1220 companies
in the Biotechnology industry
Industry Median: 2.65 vs OSTO:XBRANE: 0.79

A closely related ratio is called PB Ratio. As of today, Xbrane Biopharma AB's share price is kr0.2135. Xbrane Biopharma AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was kr0.65. Hence, Xbrane Biopharma AB's P/B Ratio of today is 0.33.


Xbrane Biopharma AB Price-to-Tangible-Book Historical Data

The historical data trend for Xbrane Biopharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Price-to-Tangible-Book Chart

Xbrane Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.70 8.51 6.87 6.99 4.15

Xbrane Biopharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 9.10 7.68 3.53 4.15

Competitive Comparison of Xbrane Biopharma AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Xbrane Biopharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xbrane Biopharma AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xbrane Biopharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Xbrane Biopharma AB's Price-to-Tangible-Book falls into.



Xbrane Biopharma AB Price-to-Tangible-Book Calculation

Xbrane Biopharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.2135/0.273
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Xbrane Biopharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Xbrane Biopharma AB (OSTO:XBRANE) Business Description

Traded in Other Exchanges
Address
Retzius vag 8, Solna, SWE, 171 65
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company has a patented protein production platform with up to 12 times greater productivity than standard systems for the production of proteins in E.coli host cells. Xbrane's leading product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. The company's geographical segments include the Middle East, Asia, Europe, and the United States.

Xbrane Biopharma AB (OSTO:XBRANE) Headlines

No Headlines